Westpac Banking Corp’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-3,481
Closed -$997K 864
2020
Q3
$997K Hold
3,481
0.01% 665
2020
Q2
$656K Hold
3,481
0.01% 731
2020
Q1
$429K Hold
3,481
0.01% 739
2019
Q4
$577K Hold
3,481
0.01% 793
2019
Q3
$426K Buy
+3,481
New +$462K 0.01% 809
2019
Q1
Sell
-10,008
Closed -$1.4M 814
2018
Q4
$1.4M Buy
+10,008
New +$1.33M 0.02% 511
2017
Q4
Sell
-6,400
Closed -$662K 784
2017
Q3
$662K Buy
+6,400
New +$477K 0.01% 615

Other funds holding ONC

Westpac Banking Corp's ONC Position: Q4 2020 in Review

Westpac Banking Corp sold out of BeOne Medicines Ltd (ONC) in Q4 2020, closing a stake of 3,481 shares — an estimated $997K sold.

Westpac Banking Corp first reported a position in ONC in Q3 2017 and held it in 7 quarters. The position peaked at $1.4M in Q4 2018. 248 funds tracked by Wall St. Rank hold ONC as of Q4 2020.

  • Westpac Banking Corp reported no remaining BeOne Medicines Ltd position as of Q4 2020 after selling out during the quarter.
  • Westpac Banking Corp sold 3,481 BeOne Medicines Ltd shares in Q4 2020, an estimated $997K.
  • Westpac Banking Corp first reported a position in BeOne Medicines Ltd in Q3 2017 and held it in 7 quarters.
  • Westpac Banking Corp's BeOne Medicines Ltd position peaked at $1.4M in Q4 2018.
  • 248 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2020.

Based on Westpac Banking Corp's 13F filing for Q4 2020, filed 11 Feb 2021.